RLI COO granted option for 8,125 shares at $58.66
RLI Corp reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RLI Corp reported an insider equity award. Chief Operating Officer Jennifer L. Klobnak acquired a stock option covering 8,125 shares at an exercise price of $58.66 per share on 11/03/2025. The option vests in 20% increments annually, beginning one year from the grant date, and expires on 11/03/2033. The filing shows the option was acquired at a price of $0 and is held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 8,125 | $0.00 | $0.00 |
Footnotes (1)
- F1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RLI (RLI) disclose in this Form 4?
What is the exercise price and size of the option grant at RLI?
How does the RLI option vest for the COO?
When does the RLI option become exercisable and when does it expire?
Was any price paid for the option by the reporting person?
What is the ownership form of the reported RLI option?
AI-generated analysis. How Rhea-AI works. Not financial advice.